6549 fundamentals
An in-depth look to TAIWANJ PHARMACEUTICALS CO LTD operating, investing, and financing activities
6549 free cash flow for H2 24 is -10.68 M TWD. For 2024, 6549 free cash flow was -20.52 M TWD and operating cash flow was -20.52 M TWD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
TTM